BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21411362)

  • 1. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011).
    Marcuzzi A; Zanin V; Crovella S; Pontillo A
    Oral Oncol; 2011 May; 47(5):436-7; author reply 438. PubMed ID: 21411362
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonate-associated osteonecrosis: experiences in a private practice.
    Marder MZ; Marder RW
    Dent Today; 2008 Oct; 27(10):99-100, 102-3; quiz 103, 98. PubMed ID: 18935863
    [No Abstract]   [Full Text] [Related]  

  • 4. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.
    Tsai KY; Huang CS; Huang GM; Yu CT
    J Rheumatol; 2010 Mar; 37(3):675; author reply 676. PubMed ID: 20197569
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing the adverse effects of bisphosphonate therapy on the jaw.
    Rizzolo D; Sedrak M
    JAAPA; 2009 Nov; 22(11):48-52. PubMed ID: 19999176
    [No Abstract]   [Full Text] [Related]  

  • 6. Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.
    Srinivasan D; Shetty S; Ashworth D; Grew N; Millar B
    Br Dent J; 2007 Jul; 203(2):91-2. PubMed ID: 17660779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse oral sequelae to bisphosphonate administration.
    Marunick M; Miller R; Gordon S
    J Mich Dent Assoc; 2005 Nov; 87(11):44-9. PubMed ID: 16372548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteonecrosis of the jaw related to the use of bisphosphonates.
    Van den Wyngaert T; Huizing MT; Vermorken JB
    Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate associated osteonecrosis of the jaw; similarities and differences in oncologic and non-oncologic patients.
    Chogle AR
    J Assoc Physicians India; 2011 Aug; 59():477-8. PubMed ID: 21887901
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
    Epstein MS; Wicknick FW; Epstein JB; Berenson JR; Gorsky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):593-6. PubMed ID: 20955948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification".
    Woo SB; Mawardi H; Treister N
    Oral Oncol; 2009 Aug; 45(8):740. PubMed ID: 19038574
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis: what does it mean? One condition partly caused by bisphosphonates--or another one, preferably treated with them?
    Aspenberg P
    Acta Orthop; 2006 Oct; 77(5):693-4. PubMed ID: 17068696
    [No Abstract]   [Full Text] [Related]  

  • 15. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.
    Assael LA
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488
    [No Abstract]   [Full Text] [Related]  

  • 16. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kyrgidis A; Vahtsevanos K
    J Craniomaxillofac Surg; 2011 Jun; 39(4):271. PubMed ID: 20434920
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

  • 18. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
    Bamias A; Terpos E; Dimopoulos MA
    Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonate associated osteonecrosis of the jaws and endodontic treatment: two case reports.
    Fugazzotto PA; Lightfoot S
    J Mass Dent Soc; 2006; 55(2):5. PubMed ID: 16937899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.